180 Life Sciences

$9.44
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.06 (-0.60%) Today
-$0.54 (-5.41%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ATNF and other stocks, options, and ETFs commission-free!

About ATNF

180 Life Sciences Corp. develops pharmaceuticals for chronic pain and inflammatory diseases. It operates as a clinical-stage biotechnology company focused on the development of novel drugs that fulfil unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University.

CEO
Jim N. Woody
Employees
—
Headquarters
Menlo Park, California
Founded
2016
Market Cap
193.40M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
7.46M
High Today
$11.00
Low Today
$9.56
Open Price
$10.45
Volume
1.44M
52 Week High
$13.05
52 Week Low
$1.90

ATNF Earnings

Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 3, Pre-Market

You May Also Like

BIOTW
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure